Rocket Pharmaceuticals (RCKT) Shareholder's Equity (2014 - 2026)
Rocket Pharmaceuticals (RCKT) Shareholder's Equity (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Rocket Pharmaceuticals |
301.08 Mn |
301.08 Mn |
- |
238.04 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
238.04 Mn |
| Dec 31, 2025 |
277.22 Mn |
| Sep 30, 2025 |
313.67 Mn |
| Jun 30, 2025 |
354.21 Mn |
| Mar 31, 2025 |
412.14 Mn |
| Dec 31, 2024 |
463.23 Mn |
| Sep 30, 2024 |
329.77 Mn |
| Jun 30, 2024 |
384.64 Mn |
| Mar 31, 2024 |
441.50 Mn |
| Dec 31, 2023 |
492.57 Mn |
| Sep 30, 2023 |
541.09 Mn |
| Jun 30, 2023 |
402.97 Mn |
| Mar 31, 2023 |
458.88 Mn |
| Dec 31, 2022 |
489.69 Mn |
| Sep 30, 2022 |
367.31 Mn |
| Jun 30, 2022 |
387.70 Mn |
| Mar 31, 2022 |
417.62 Mn |
| Dec 31, 2021 |
454.72 Mn |
| Sep 30, 2021 |
485.66 Mn |
| Jun 30, 2021 |
489.44 Mn |
